Credo Technology Group Holding Ltd heads into its fiscal Q4 print tonight having given back ground from last week's peak, with the stock at $226.10 — down 4% on the day but still up 23% over the past month and sitting well above where any analyst on the Street has set a target.
The day's pullback is the first real wrinkle in a story that has been relentlessly bullish. CRDO hit $236 on Friday; it is now roughly $10 below that. Options positioning reflects a mild shift toward calls: the put/call ratio has eased to 0.80, about 1.3 standard deviations below its 20-day average of 0.88. That is more bullish than typical — traders are not hedging into the print the way they might be expected to after a 23% monthly run. The borrow market adds nothing to the tension. Availability has expanded dramatically over the past week to nearly 4,961% — meaning the lending pool is essentially empty of demand relative to supply — and cost to borrow has fallen 27% over the same period to just 0.33%. Short interest, at 5.47% of the free float, has edged up fractionally from the May 26 low but remains well below the mid-May peak near 5.9%. There is no squeeze dynamic here, and no sign of fresh short conviction building into the report.
The central debate is not about growth — it is about whether the valuation has run ahead of even the most optimistic read of the business. The Street's mean price target is $221, now below Monday's close. Mizuho's Vijay Rakesh raised his target to $260 just yesterday, maintaining Outperform — the most aggressive published number in the current cycle and one of the few targets sitting above the stock. Goldman Sachs raised to $170 in mid-April and is already deeply underwater. The bull case rests on >75% revenue growth in FY27, driven by hyperscaler adoption of AECs and a $500M-plus optical division contribution from the DustPhotonics acquisition. Bears point to customer concentration risk, heavy reliance on outsourced manufacturing, and the upfront cost of integrating DustPhotonics — a combination that could weigh on margins even if top-line numbers impress. EPS momentum is exceptional, ranking in the 97th percentile on a 30-day basis, which tells you estimate revisions have been running hot. The earnings surprise history is more mixed at the 38th percentile — the company does not always beat by wide margins when it matters most.
One institutional data point is worth noting. Point72 built a position of 7.5 million shares as of March 31, adding nearly 1.9 million in the quarter — a meaningful commitment from an active manager known for high-conviction positioning. BlackRock added roughly 1 million shares through April. On the insider side, the moves are all in one direction: Founder and CTO Lawrence Cheng sold approximately 18,000 shares on May 1 across multiple tranches, and CLO James Laufman sold 7,400 shares on May 19. Both are likely programmatic, but the 90-day net position across all insiders is a modest $14.9M of net selling — not alarming at this stock price, but not a vote of confidence either. After the March print drove a 17% one-day gain, tonight's report tests a stock that has already priced in much of that enthusiasm at a still-higher level.
The print is less about whether CRDO can grow at speed and more about whether the optical revenue ramp and margin trajectory justify a stock price that has outrun every analyst target except one set just 24 hours ago.
See the live data behind this article on ORTEX.
Open CRDO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
